- Home
- USAC vs DNLI Comparison
USAC vs DNLI Comparison
Compare USAC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USAC | DNLI |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.5B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | USAC | DNLI |
|---|---|---|
| Price | $24.59 | $17.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 14 |
| Target Price | $25.00 | ★ $32.58 |
| AVG Volume (30 Days) | 204.2K | ★ 1.7M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 8.54% | N/A |
| EPS Growth | ★ 43.67 | N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $991,507,000.00 | N/A |
| Revenue This Year | $7.32 | N/A |
| Revenue Next Year | $4.22 | $3,993.60 |
| P/E Ratio | $30.41 | ★ N/A |
| Revenue Growth | ★ 6.66 | N/A |
| 52 Week Low | $21.53 | $10.57 |
| 52 Week High | $30.10 | $24.69 |
Technical Indicators
Market Signals| Indicator | USAC | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 58.21 | 46.99 |
| Support Level | $24.02 | $17.20 |
| Resistance Level | $24.67 | $20.61 |
| Average True Range (ATR) | 0.66 | 0.98 |
| MACD | -0.03 | -0.25 |
| Stochastic Oscillator | 47.17 | 8.64 |
Price Performance
Historical ComparisonAbout USAC USA Compression Partners LP Common Units Representing Limited Partner Interests
USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services in several shale plays throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.